Medicine composition containing iodized lecithin and preparation method thereof

A technology containing lecithin and complexed iodine, which is applied in drug combinations, medical preparations containing active ingredients, and pharmaceutical formulas, etc., can solve problems such as ineffective drug treatment, treating symptoms but not root causes, etc., to increase retinal metabolism and regulate liver function. Kidney, the effect of regulating autoimmune function

Inactive Publication Date: 2016-09-07
钟志敏
View PDF1 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] Cataract drug treatment has no definite effect. At present, both at home and abroad are in the stage of exploratory research, including drug treatment and surgical treatment. At present, most of the clinical drugs are mainly to relieve symptoms, and treat the symptoms rather than the root cause. Although surgical treatment has a certain curative effect, some The patient is relatively old, and the trauma caused by the operation and postoperative recovery have become a new problem. Therefore, on the premise that drug treatment can be used as much as possible, drug treatment is selected. Therefore, it is necessary to relieve the cataract symptoms and improve the eye. Metabolic cycle, enhance eye nutrition, so as to achieve the effect of preventing and treating cataract, this is the problem we want to study

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0017] A pharmaceutical composition containing lecithin complexed iodine, which is mainly composed of the following ingredients in parts by weight: 0.6 parts of lecithin complexed iodine, 0.3 parts of phenobarbital, 12 parts of kaempferol, 10 parts of diosmin, 8.5 parts of stachydrine, 7 parts of blueberry anthocyanins, 5.3 parts of luteolin, 4.2 parts of chitin, 3.9 parts of tribulus terrestris saponins, 3.4 parts of α-linolenic acid, 2.7 parts of taurine, 0.05 parts of riboflavin, nicotinic acid 0.04 parts, 0.008 parts of amino acids, 10 parts of fillers, 5 parts of binders, 7 parts of disintegrants, and 1.0 parts of lubricants.

[0018] Wherein, the blueberry anthocyanin is a flavonoid compound extracted from blueberries, which can promote the resynthesis of rhodopsin in the dark, and rhodopsin can be decomposed instantly when the retina is stimulated by light, and the chemical The changes are transmitted to the brain, thereby producing "visible objects", thereby improving ...

Embodiment 2

[0023] A pharmaceutical composition containing lecithin complexed iodine, which is mainly composed of the following ingredients in parts by weight: 1.2 parts of lecithin complexed iodine, 0.7 parts of phenobarbital, 20 parts of kaempferol, 17.5 parts of diosmin, 16 parts of stachydrine, 13 parts of blueberry anthocyanins, 11.4 parts of luteolin, 9.8 parts of chitin, 8.7 parts of tribulus terrestris saponins, 7.5 parts of α-linolenic acid, 6.5 parts of taurine, 0.11 parts of riboflavin, niacin 0.09 parts, 0.017 parts of amino acids, 22 parts of fillers, 11.5 parts of binders, 14 parts of disintegrants, and 2.3 parts of lubricants.

[0024]Wherein, the blueberry anthocyanin is a flavonoid compound extracted from blueberries, which can promote the resynthesis of rhodopsin in the dark, and rhodopsin can be decomposed instantly when the retina is stimulated by light, and the chemical The changes are transmitted to the brain, thereby producing "visible objects", thereby improving th...

Embodiment 3

[0029] A pharmaceutical composition containing lecithin-complexed iodine, mainly composed of the following ingredients in parts by weight: 1.8 parts of lecithin-complexed iodine, 1.1 parts of phenobarbital, 28 parts of kaempferol, 25 parts of diosmin, 23.5 parts of stachydrine, 19 parts of blueberry anthocyanins, 17.5 parts of luteolin, 15.4 parts of chitin, 13.5 parts of tribulus terrestris saponins, 11.6 parts of α-linolenic acid, 10.3 parts of taurine, 0.17 parts of riboflavin, nicotinic acid 0.14 parts, 0.026 parts of amino acids, 34 parts of fillers, 18 parts of binders, 21 parts of disintegrants, and 3.6 parts of lubricants.

[0030] Wherein, the blueberry anthocyanin is a flavonoid compound extracted from blueberries, which can promote the resynthesis of rhodopsin in the dark, and rhodopsin can be decomposed instantly when the retina is stimulated by light, and the chemical The changes are transmitted to the brain, thereby producing "visible objects", thereby improving ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a medicine composition containing iodized lecithin and a preparation method thereof. The medicine composition containing iodized lecithin mainly comprises the following components: iodized lecithin, kaempferol, diosmin, stachydrine, blueberry anthocyanins, luteolin, chitin, puncturevine caltrop fruit saponins, phenobarbital, alpha-linolenic acid, taurine, riboflavin, nicotinic acid, amino acid, a filling agent, an adhesive, a disintegrating agent and a lubricating agent. The medicine composition has the beneficial effects that various effective components are combined through reasonable proportioning; the medicine composition achieves the functions of improving eyesight, eliminating ocular inflammation, increasing retina metabolism and regulating autoimmunity by improving ocular blood circulation, increasing corneal nutrition, resisting inflammation and oxidation and regulating the liver and kidneys, and has good prevention and treatment effects on cataract.

Description

technical field [0001] The invention relates to the technical field of ophthalmic medicine, in particular to a pharmaceutical composition containing lecithin complexed iodine and a preparation method thereof. Background technique [0002] All kinds of reasons, such as aging, genetics, local nutritional disorders, immune and metabolic abnormalities, trauma, poisoning, radiation, etc., can cause lens metabolic disorders, resulting in lens protein denaturation and opacity, which is called cataract. Obstructions cannot be projected on the retina, and objects cannot be seen clearly. From the perspective of preventing and treating blindness in groups, the World Health Organization considers the denaturation and turbidity of the lens, which becomes opaque, and affects vision. Only those whose corrected vision is 0.7 or below are included in the scope of cataract diagnosis. Cataracts are divided into congenital cataracts and acquired cataracts. Congenital cataracts usually exist be...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/185A61K9/16A61P27/12
CPCA61K31/685A61K9/1652A61K31/185A61K31/198A61K31/202A61K31/352A61K31/40A61K31/405A61K31/455A61K31/515A61K31/525A61K31/7048A61K31/722A61K36/185A61K2300/00
Inventor 钟志敏
Owner 钟志敏
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap